HAW/240 (Xpect-AT 60 mg-600 mg)
Generic Name: carbetapentane/guaifenesin
Pill imprint HAW/240 has been identified as Xpect-AT 60 mg-600 mg.
Xpect-AT is used in the treatment of cough and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Xpect-AT 60 mg-600 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- 60 mg-600 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Hawthorn Pharmaceuticals
More about Xpect-AT (carbetapentane / guaifenesin)
- Side Effects
- Dosage Information
- Drug Interactions
- Support Group
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: upper respiratory combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.